The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Movsisyan G.A.

Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Martynyuk T.V.

The Institute of Clinical Cardiology named after A.L. Myasnikov, Federal State Institution «National Medical Research Center of Сardiology», Moscow, Russia

Mershin K.V.

Department of Cardiovascular Surgery, A.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Russian Ministry of Health, Moscow, Russia

Danilov N.M.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Satybaldyeva M.A.

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

Reshetniak T.M.

FGBU "NII revmatologii" RAMN

Akchurin R.S.

FGBU National medical research cardiology center of Russia, Moscow, Russia

Nasonov E.L.

"Research Institute of rheumatology n. a. V. A. Nasonova"

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome

Authors:

Movsisyan G.A., Martynyuk T.V., Mershin K.V., Danilov N.M., Satybaldyeva M.A., Reshetniak T.M., Akchurin R.S., Nasonov E.L., Chazova I.E.

More about the authors

Journal: Therapeutic Archive. 2017;89(9): 93‑99

DOI: 10.17116/terarkh201789993-99

Read: 2384 times

Download PDF (RU)
Contact the author
Table of contents

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION DEVELOPED IN A FEMALE PATIENT WITH LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION DEVELOPED IN A FEMALE PATIENT WITH LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME

To cite this article:

Movsisyan GA, Martynyuk TV, Mershin KV, et al. . Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome. Therapeutic Archive. 2017;89(9):93‑99. (In Russ.)
https://doi.org/10.17116/terarkh201789993-99

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Asse­ssment of central hemo­dynamic para­meters after pulmonary thro­mbendarterectomy in patients with chro­nic thro­mboembolic pulmonary hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):637-645
Central nervous system invo­lvement in systemic lupus erythematosus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):124-129
Masks of autoimmune diseases: a multidisciplinary approach to the problem. Journal of Respiratory Medi­cine. 2025;(1):58-64
Features of early postoperative period in patients with chro­nic thro­mboembolic pulmonary hype­rtension with concomitant supraventricular arrhythmias. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):300-305
Abstract:

Chronic thromboembolic pulmonary hypertension (CTEPH) is one of the potentially curable forms of pulmonary hypertension, in which pulmonary thromboendarterectomy is the gold standard treatment. However, over the last decade, great attention has been given to a combined therapeutic approach including both drug therapy and surgical treatment and the application of endovascular technologies. This clinical case demonstrates the diagnostic difficulties of CTEPH and the opportunities of a comprehensive approach to therapy for the disease with mandatory assessment of preoperative surgical and medical treatment in order to improve the patient status and to prepare for surgery.

Keywords:

chronic thromboembolic pulmonary hypertension
systemic lupus erythematosus
specific therapy

Authors:

Movsisyan G.A.

Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Martynyuk T.V.

The Institute of Clinical Cardiology named after A.L. Myasnikov, Federal State Institution «National Medical Research Center of Сardiology», Moscow, Russia

Mershin K.V.

Department of Cardiovascular Surgery, A.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Russian Ministry of Health, Moscow, Russia

Danilov N.M.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Satybaldyeva M.A.

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

Reshetniak T.M.

FGBU "NII revmatologii" RAMN

Akchurin R.S.

FGBU National medical research cardiology center of Russia, Moscow, Russia

Nasonov E.L.

"Research Institute of rheumatology n. a. V. A. Nasonova"

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

Close metadata

References:

  1. Lang IM, Pesavento R, Bonderman D, Yuan J-X. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. European Respiratory Journal. 2013;41:462-468. https://doi.org/10.1183/09031936.00049312
  2. Wolf M, Boyer-Neumann C, Parent F et al. Thrombotic risk factors in pulmonary hypertension. European Respiratory Journal. 2000;15:395-399. https://doi.org/10.1034/j.1399-3003.2000.15b28.x
  3. Moser KM, Auger WR, and Fedullo PF: Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990; 81:1735-1743. https://doi.org/10.1161/01.CIR.81.6.1735
  4. Pulmonary hypertension. Monograph by Chazova I, Martynyuk T. Moscow: Practica; 2015. (In Russ.).
  5. Madani MM, Auger WR, Pretorius V et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. The Annals of Thoracic Surgery. 2012;94:97-103. https://doi.org/10.1016/j.athoracsur.2012.04.004
  6. Mizoguchi H, Ogawa A, Munemasa M et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circulation: Cardiovascular Interventions. 2012;5:748-755. https://doi.org/10.1161/CIRCINTERVENTIONS.112.971077
  7. Galiè N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Respiratory Journal. 2015;46:903-975. https://doi.org/10.1183/13993003.51032-2015
  8. Hossein-Ardeschir Ghofrani, Andrea M D’Armini et al. for the CHEST-1 Study Group: «Riociguat for the Treatment of Pulmonary Arterial Hypertension». New England Journal of Medicine. 2013;369:319-329. https://doi.org/10.1056/NEJMoa1209657
  9. Reshetnyak TM. Systemic lupus erythemathosus. Rheumatology. Clinical lectures. Edited by prof. Badokina VV. Moscow: Littera; 2012; 245-331. (In Russ.).
  10. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis. 2006;4:295-306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
  11. Reshetnyak TM, Vavilova TV. Clinical and laboratory criteria for diagnosing the antiphospholipid syndrome: what is it important for the practitioner to know (a lecture). Klinicheskaya laboratornaya diagnostika. 2010;5:12-20. (In Russ.).
  12. Reshetnyak TM, Radenska-Lopovok SG, Aleksandrova EN, Kondratyeva LV et al. Lung Pathology in Antiphospholipid Syndrome. General Reanimatology. 2005;1(5):34-43. (In Russ.).https://doi.org/10.15360/1813-9779-2005-5-34-43
  13. Cervera R, Piette JC, Font J, Khamashta MA et al.; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism. 2002;46(4):1019-1027. https://doi.org/10.1002/art.10187
  14. Erkan D, Pierangeli S, Lockshin M. Task Force Report on Antiphospholipid Syndrome Clinical Research. Antiphospholipid Syndrome. 2012:247-257. https://doi.org/10.1007/978-1-4614-3194-7_17
  15. Berkun Y, Elami A, Meir K et al. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. The Journal of Thoracic and Cardiovascular Surgery. 2004;127(2):414-420. https://doi.org/10.1016/j.jtcvs.2003.07.016
  16. Massoudy P, Cetin S, Thielman M et al. Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder? European Journal of Cardio-Thoracic Surgery. 2005;28(1):133-137. https://doi.org/10.1016/j.ejcts.2004.12.062
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.